Microalgae-derived EPA oil is a next-generation sustainable Omega-3 ingredient produced from Nannochloropsis microalgae, a natural primary producer of eicosapentaenoic acid (EPA). Unlike traditional marine oils derived from fish or krill, microalgae EPA is produced directly from photosynthetic microalgae cultivation, providing a pure, marine-independent, and environmentally responsible source of Omega-3 fatty acids.
This microalgae oil is naturally rich in polar lipids, including phospholipids, glycolipids, and betaine lipids, which contribute to superior biological absorption compared with conventional triglyceride-type fish oils. The unique lipid composition supports efficient delivery of EPA in the human body and may play a role in lipid metabolism, cardiovascular health, and anti-inflammatory pathways.
Microalgae EPA oil contains EPA without DHA, making it particularly suitable for formulations focusing specifically on cardiovascular health and triglyceride management. In addition, the absence of marine food-chain contaminants provides an additional safety advantage for high-purity nutritional applications.
The ingredient is widely used in dietary supplements, functional foods, nutraceutical formulations, and pharmaceutical intermediate research. With increasing global demand for sustainable Omega-3 sources, microalgae EPA oil has emerged as a leading alternative to fish-derived oils.
This product is suitable for softgels, capsules, functional beverages, nutrition powders, and other health-oriented formulations. OEM and customized specifications are available to meet specific formulation requirements for global manufacturers.
Request Product Information
Please share your requirements below.
* B2B inquiries only
* Confidential information protected
* No spam or marketing emails
SPMs-Rich Microalgae Omega-3 EPA Oil is an advanced marine-free omega-3 ingredient derived from the microalga Nannochloropsis. Produced through controlled photosynthetic cultivation systems, this natural algae oil is rich in eicosapentaenoic acid (EPA) and specialized pro-resolving mediators (SPMs), which play a critical role in inflammation resolution and immune balance.
Unlike conventional fish oil or krill oil extracted from marine organisms, microalgae are the primary producers of omega-3 fatty acids in the marine ecosystem. This enables production without food-chain contamination risks, such as heavy metals or environmental pollutants. Through targeted cultivation and advanced extraction technologies, the oil naturally accumulates high levels of EPA and bioactive lipid mediators that support inflammation resolution pathways.
SPMs are bioactive lipid molecules derived from omega-3 fatty acids that help regulate the body’s natural inflammatory response. Scientific studies suggest that SPMs may contribute to joint comfort, respiratory health, immune balance, and post-recovery support. This makes SPMs-rich algae oil a promising next-generation ingredient for high-end nutraceuticals, functional foods, and pharmaceutical research.
With its plant-based origin, high purity, and superior bioavailability compared with traditional marine oils, SPMs-rich microalgae oil is suitable for a wide range of applications including anti-inflammatory formulations, joint health supplements, immune support products, post-recovery nutrition, respiratory health formulations, and advanced omega-3 supplements.
Bulk supply and OEM customization are available for global manufacturers in nutraceutical, pharmaceutical, and functional food industries.
Request Product Information
Please share your requirements below.
* B2B inquiries only
* Confidential information protected
* No spam or marketing emails